Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Placebo Controlled, Double Blind Clinical Trial to Evaluate the Efficacy of Molecule D11AX22 in Adults Patients From Valle Del Cauca, Colombia With Early Stages of SARS COV2 / COVID-19

NCT04405843 is registered in ClinicalTrials.gov with Centro de Estudios en Infectogía Pediatrica as lead sponsor.

NCT NCT04405843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04405843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Placebo Controlled, Double Blind Clinical Trial to Evaluate the Efficacy of Molecule D11AX22 in Adults Patients From Valle Del Cauca, Colombia With Early Stages of SARS COV2 / COVID-19
Lead sponsor
Centro de Estudios en Infectogía Pediatrica
Phase
Phase 2/3
Overall status
Completed
Start date
July 14, 2020
Completion date
December 21, 2020
Enrollment
476 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19